Alzheimer’s Drug Discovery Foundation Statement on Today’s FDA Independent Panel Vote on Biogen’s Aducanumab

NEW YORK, Nov. 6, 2020 /PRNewswire/ — An independent FDA advisory committee today signaled in several votes that it does not believe the clinical study data for Biogen’s aducanumab supports the drug’ …
(Orginal – Story lesen…)

This website stores some user agent data. These data are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to opt-out of any future tracking, a cookie will be set up in your browser to remember this choice for one year. I Agree, Deny
722